Prevention of Hernia After Loop Ileostomy Reversal

Launched by KAROLINSKA INSTITUTET · Oct 24, 2018

Keywords

ClinConnect Summary

This clinical trial, called PHaLIR, is studying how to prevent hernias after a specific type of surgery known as loop ileostomy reversal, which some patients may need after having surgery for rectal cancer. In this trial, patients who are having their stoma (an opening created during surgery) reversed will be randomly assigned to receive either a special mesh called Ultrapro Advanced to help support the area or standard treatment without the mesh. The goal is to see if using this mesh can reduce the chances of developing a hernia after the surgery.

To be eligible for this trial, patients must have undergone a specific type of surgery for rectal cancer and are planning to reverse their loop ileostomy. However, those who have language barriers, cognitive disabilities, or recurrent cancer are not able to participate. If you join the trial, you can expect to receive either the mesh treatment or standard care, and your progress will be monitored to help researchers understand the best approach for preventing hernias in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients operated for low anterior resection for rectal cancer with a diverting loop ileostomy and planned for stoma reversal
• Exclusion Criteria:
• • Language barrier or cognitive disability
• • Recurrent cancer